Biomarkers in lung cancer.
Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.
Bearz
Alessandra
A
Department of Medical Oncology, CRO-IRCCS, National Cancer Institute, Aviano, PN, Italy. abearz@cro.it
Berretta
Massimiliano
M
Cappellani
Alessandro
A
Lleshi
Arben
A
Berto
Eleonora
E
Fratino
Lucia
L
Tirelli
Umberto
U
D014408:Biomarkers, Tumor / Q000097:blood*; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood*; D018288:Carcinoma, Small Cell / Q000097:blood*; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood*
D014408:Biomarkers, Tumor